Although there was no difference in the CRP and venous lactate value between the two groups, the WBC was significantly lower in the BC patients than it was in the non-BC patients (6.9 (IQR 5.5–10.2) vs. 9.9 (IQR 7.5–13.6), p < 0.0). This evidence concerns the gene CRP and breast cancer.